Cardiovascular Studies

Employ PPD’s extensive experience in cardiovascular drug development for the planning and implementing of your Phase I-IV programs. Our worldwide investigator database includes more than 1,450 cardiologists, and our association with leading cardiology sites in the United States and Europe enables efficient subject recruitment to match study protocol requirements. In the past five years, PPD has recruited approximately 60,000 subjects at 9,000 sites worldwide for more than 110 cardiovascular protocols.

Our clinical trial experience includes:

• Acute myocardial infarction
• Angina
• Atrial fibrillation
• Congestive heart failure
• Coronary artery disease
• Hemorrhagic shock
• Hypertension
• Stroke

Dedicated Project Teams

Ensure seamless continuity for the duration of your project with our dedicated cardiovascular drug development teams. Each is led by experienced project managers and includes:

• Cardiologists
• Medical directors
• Regulatory professionals
• Data managers
• CRAs trained and experienced in cardiovascular protocols

Cardiovascular Device Expertise

Whether treating chronic heart failure or finding improved technologies to reconnect arteries, PPD has extensive experience in managing device projects through our specialized division, PPD Medical Device, including:

• Drug-eluting stents
• Radiation therapies
• Distal protection devices